Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.
about
The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes.Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesisAssociation of glycaemia with lipids in adults with type 1 diabetes: modification by dyslipidaemia medication.Anti-atherogenic potential of jujube, saffron and barberry: anti-diabetic and antioxidant actions.Lipoprotein(a) and cardiovascular disease in diabetic patientsLong-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study.Prevalence and determinants of elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type 2 diabetesAssociations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes.Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: the TODAY clinical trialCardiovascular risk factors among youth with and without type 2 diabetes: differences and possible mechanisms.Lipoprotein (a): impact by ethnicity and environmental and medical conditionsEffect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial.LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetesRelationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial.Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes.Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program.Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia.Lipoprotein(a) in health and disease.Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.Testosterone administration to men increases hepatic lipase activity and decreases HDL and LDL size in 3 wk.The effect of long-term glycaemic control on serum lipoprotein(a) levels in patients with Type 2 diabetes mellitus.
P2860
Q33771752-88CFDC30-598F-4E19-AEA5-7F52C5B1B5FDQ36052417-2215F0B3-5463-44F0-BCCC-054E59CA100EQ36117272-C6C99F37-9DE8-4767-B940-1C56AD67519EQ36294496-16EC8278-2A1C-472E-A3AE-46C50B16DB29Q36369444-B23A1432-38E8-4B39-8C45-E91E92A74BB7Q36472753-E743CD17-4B2F-435E-95BC-4DFB37EE786BQ36494412-3C7619B7-9115-4EB6-8B1E-178D1606210EQ36503844-5884E6C3-2D06-4355-A654-A191922A19A6Q36868110-A2A0EABB-A836-4C80-ACAF-D6B03AF840F4Q37022802-39949E03-1AE9-4248-AFD6-AB9CF7D5DF5BQ37033161-BC13FB08-FC63-4341-BC01-4F263BF0F386Q37055003-FF8EEBD2-F5AA-49E6-84C1-8F3D77A373C2Q37066037-E222ADEB-3CF6-4656-AC88-1028FF68C0CEQ37076749-316AB125-89F7-4163-A645-6D68FA612601Q37082025-081E09B4-7311-490C-A9A2-0EC1C41A2F1EQ37215490-EF7D2161-5DA2-4B8D-A306-15107F49896FQ37530315-5507A50E-8CB5-4C23-B457-7050EA560B37Q41300659-441840AF-CD6B-49D7-B79A-488ADA9769C3Q44398229-40126CD8-FAE5-4EA8-82A0-37E355888C0DQ44433201-DFA75FA0-FC34-454C-8C54-445FEC9E6B7AQ51558534-7207FD50-F600-428B-B5B3-C4EA3077EB37
P2860
Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.
description
1995 nî lūn-bûn
@nan
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Levels of lipoprotein(a), apol ...... ntrol and Complications Trial.
@ast
Levels of lipoprotein(a), apol ...... ntrol and Complications Trial.
@en
type
label
Levels of lipoprotein(a), apol ...... ntrol and Complications Trial.
@ast
Levels of lipoprotein(a), apol ...... ntrol and Complications Trial.
@en
prefLabel
Levels of lipoprotein(a), apol ...... ntrol and Complications Trial.
@ast
Levels of lipoprotein(a), apol ...... ntrol and Complications Trial.
@en
P2093
P2860
P356
P1433
P1476
Levels of lipoprotein(a), apol ...... ntrol and Complications Trial.
@en
P2093
J D Brunzell
J E Hokanson
J Q Purnell
M W Steffes
P A Cleary
S M Marcovina
P2860
P304
P356
10.2337/DIAB.44.10.1218
P407
P577
1995-10-01T00:00:00Z